Asarfi Hospital (BOM:543943) Research & Development: ₹0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543943 Asarfi Hospital Ltd BOM:543943
71 GF Score
Price ₹221.40
GF Value ₹206.60
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Asarfi Hospital Research & Development?

Asarfi Hospital BOM:543943 -5.32% 71 Research & Development is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:543943 with a GF Score™ of 71/100 and a GF Value™ of ₹206.60 (Fairly Valued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Asarfi Hospital's Research & Development for the three months ended in Jun. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0 Mil.

Asarfi Hospital  (BOM:543943) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Asarfi Hospital Research & Development Related Terms

Asarfi Hospital Research & Development Historical Data

* Premium members only.

The historical data trend for Asarfi Hospital's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asarfi Hospital Research & Development Chart

Asarfi Hospital Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Asarfi Hospital Quarterly Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:543943
71GF Score
Asarfi Hospital Ltd BOM:543943
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asarfi Hospital Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Asarfi Hospital (BOM:543943) has a Research & Development of ₹0 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Asarfi Hospital and its competitors.
Is Asarfi Hospital's Research & Development too high?
Asarfi Hospital's current Research & Development is ₹0 Mil. Overall, Asarfi Hospital has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Asarfi Hospital's Research & Development compare to HCA and THC?
Asarfi Hospital's Research & Development of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Asarfi Hospital and its competitors. Asarfi Hospital's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asarfi Hospital stock overvalued right now?
Based on GuruFocus' analysis, Asarfi Hospital (BOM:543943) is currently considered Fairly Valued. The stock's GF Value™ is ₹206.60, compared to a current price of ₹221.40 — trading 7.2% above its estimated fair value. The current Research & Development is ₹0 Mil. Asarfi Hospital's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Asarfi Hospital (BOM:543943), the current Research & Development is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Asarfi Hospital (BOM:543943) Overvalued in 2026?

Based on GuruFocus' analysis, Asarfi Hospital stock appears to be overvalued. The current stock price of ₹221.40 is trading 7.2% above its estimated GF Value™ of ₹206.60. GuruFocus considers Asarfi Hospital to be Fairly Valued.

Key valuation signals for BOM:543943:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹206.60 vs. price of ₹221.40 (7.2% above fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the BOM:543943 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Asarfi Hospital Business Description

Address Bishunpur Polytechnic, 4th floor Asarfi Hospital, Baramuri, Dhanbad, JH, IND, 828130
Asarfi Hospital Ltd provides healthcare facilities to the people of Jharkhand. It is a multi-specialty hospital offering healthcare facilities. The company is committed to delivering valued healthcare services to patients that include prevention, treatment, and proper rehabilitation.
71GF Score

Get the complete analysis for BOM:543943

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹221.40
Price
₹206.60
GF Value